La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the development of therapies to treat human diseases that comprise cancer and chronic organ failure. Its lead product includes GCS , a clinical stage inhibitor designed to sequester and eliminate circulating levels of galectin for treating cancer with renal insufficiency and preventing chemotherapy toxicity, as well as for renal transplantation and cancer immunotherapy. The company is also developing LJPC , a subcutaneous formulation of GCS for renal transplantation and end stage renal disease LJPC , a synthetic galectin antagonist for heart failure and hepatic fibrosis and LJPC , a biological galectin antagonists for solid tumors. La Jolla Pharmaceutical Company was founded in and is headquartered in San Diego, California.
Quote | La Jolla Pharmaceutical Company (NASDAQ:LJPC)
Last: | $6.22 |
---|---|
Change Percent: | 0.0% |
Open: | $6.21 |
Close: | $6.22 |
High: | $6.24 |
Low: | $6.2 |
Volume: | 267,682 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | La Jolla Pharmaceutical Company (NASDAQ:LJPC)
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
NEW YORK, NY / ACCESSWIRE / August 4, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: RealNetworks, Inc. (NASDAQ:RNWK)'s ...
Message Board Posts | La Jolla Pharmaceutical Company (NASDAQ:LJPC)
Subject | By | Source | When |
---|---|---|---|
znewcar1: LJPC 81% v6M c6.14 f25,5M H6.18 | znewcar1 | investorshangout | 07/11/2022 8:13:51 PM |
whytestocks: $LJPC News Article - Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch | whytestocks | investorshangout | 07/11/2022 2:10:51 PM |
whytestocks: $LJPC News Article - LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sa | whytestocks | investorshangout | 07/11/2022 2:05:49 PM |
whytestocks: $LJPC News Article - Innoviva to Acquire La Jolla Pharmaceutical Company | whytestocks | investorshangout | 07/11/2022 2:00:50 PM |
Innoviva to Acquire La Jolla Pharmaceutical Company | starbuxsux | investorshub | 07/11/2022 1:32:09 PM |
News, Short Squeeze, Breakout and More Instantly...
La Jolla Pharmaceutical Company Company Name:
LJPC Stock Symbol:
NASDAQ Market:
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
The biotech investment sector has always been its own market, very distinct from other sectors. So it was no surprise that when most sectors turned slowly upward after the pandemic-inspired crash, Biotech (XBI) rose 164%, exceeding the overall market (SPY) performance by triple digits. Then, a...